RETRACTION: The lncRNA SNHG5-mediated miR-20-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1 (Retraction of Vol 9, Pg 4251, 2020)

被引:0
|
作者
Xiang, W.
Lv, L.
Zhou, G.
机构
来源
CANCER MEDICINE | 2023年 / 12卷 / 04期
关键词
D O I
10.1002/cam4.5090
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:5172 / 5172
页数:1
相关论文
共 50 条
  • [1] RETRACTED: The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1 (Retracted Article)
    Xiang, Wei
    Lv, Lei
    Zhou, Gaofeng
    Wu, Wei
    Yuan, Jingdong
    Zhang, Chuanhua
    Jiang, Guosong
    CANCER MEDICINE, 2020, 9 (12): : 4251 - 4264
  • [2] RETRACTION: LncRNA SNHG16 promotes migration and invasion through suppression of CDKN1A in clear cell renal cell carcinoma (Retraction of Vol 24, Pg 3572, 2020)
    Liu, S. -B.
    Wang, H. -F.
    Xie, Q. -P.
    Li, G.
    Zhou, L. -B.
    Hu, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7216 - 7216
  • [3] RETRACTION: LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p (Retraction of Vol 23, Pg 10691, 2019)
    He, G. -Z.
    Yu, S. -Y.
    Zhou, Q. -P.
    Chen, M. -L.
    Zhang, Y. -W.
    Zheng, Y.
    Zhang, Z. -B.
    Han, Z. -Y.
    Yu, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 10920 - 10920
  • [4] RETRACTION: lncRNA ROR promotes the progression of renal cell carcinoma through the miR-206/VEGF axis (Retraction of Vol 20, Pg 3782, 2019)
    Shi, Jianguo
    Zhang, Datian
    Zhong, Zhenhai
    Zhang, Wen
    MOLECULAR MEDICINE REPORTS, 2024, 29 (06)
  • [5] RETRACTION: Effects of LncRNA HCP5/miR-214-3p/MAPK1 Molecular Network on Renal Cell Carcinoma Cells (Retraction of Vol 12, Pg 13347, 2020)
    Hao, J. F.
    Chen, P.
    Li, H. Y.
    Zhang, Y. L.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 363 - 363
  • [6] RETRACTION: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation (Retraction of Vol 20, art no 90, 2020)
    Gao, Jin
    Yuan, Yuan
    Zhang, Lili
    Yu, Shaorong
    Lu, Jianwei
    Feng, Jifeng
    Hu, Sainan
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [8] RETRACTION: HnRNP A1-mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 (vol 39, 116, 2020) (Retraction of Vol 39, Pg 116, 2020)
    Sun, Guoliang
    Zhou, Hui
    Chen, Ke
    Zeng, Jin
    Zhang, Yangjun
    Yan, Libin
    Yao, Weimin
    Hu, Junhui
    Wang, Tao
    Xing, Jinchun
    Xiao, Kefeng
    Wu, Lily
    Ye, Zhangqun
    Xu, Hua
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [9] RETRACTION: miR-488 Inhibits Cell Growth and Metastasis in Renal Cell Carcinoma by Targeting HMGN5 (Retraction of Vol 11, Pg 2205, 2018)
    Wei, X.
    Yu, L.
    Kong, K.
    ONCOTARGETS AND THERAPY, 2021, 14 : 3351 - 3351
  • [10] RETRACTION: miR-660-5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma (Retraction of Vol 17, Pg 2051, 2018)
    He, Tao
    Chen, Peijie
    Jin, Lu
    Hu, Jia
    Li, Yifan
    Zhou, Liang
    Yang, Shangqi
    Mao, Xiangming
    Gui, Yaoting
    Chen, Yun
    Lai, Yongqing
    MOLECULAR MEDICINE REPORTS, 2024, 29 (05)